Soleno Therapeutics, Inc. Insider Transactions
Purchase
Sell
Soleno Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Huang Michael F.
Sr. VP of Clinical Development |
Sell | 836 @ $69.84 | $58,384 | 37,047 | 03/27/2025 | 03/31/2025 | |
|
Mackaness James H
CHIEF FINANCIAL OFFICER |
Sell | 6,498 @ $68.79 | $446,985 | 109,974 | 03/27/2025 | 03/31/2025 | |
|
Huang Michael F.
Sr. VP of Clinical Development |
Sell | 371 @ $65.97 | $24,475 | 41,029 | 03/27/2025 | 03/31/2025 | |
|
Yen Kristen
SEE REMARKS |
Sell | 50,156 @ $66.00 | $3.31 M | 51,618 | 03/27/2025 | 03/31/2025 | |
|
Yen Kristen
SEE REMARKS |
Sell | 597 @ $71.74 | $42,831 | 61,227 | 03/27/2025 | 03/31/2025 | |
|
Huang Michael F.
Sr. VP of Clinical Development |
Sell | 604 @ $66.79 | $40,342 | 40,425 | 03/27/2025 | 03/31/2025 | |
|
Manning Meredith
Chief Commercial Officer |
Sell | 1,505 @ $69.84 | $105,105 | 45,765 | 03/27/2025 | 03/31/2025 | |
|
Yen Kristen
SEE REMARKS |
Sell | 91 @ $72.64 | $6,610 | 61,136 | 03/27/2025 | 03/31/2025 | |
|
Manning Meredith
Chief Commercial Officer |
Sell | 34 @ $72.64 | $2,470 | 45,351 | 03/27/2025 | 03/31/2025 | |
|
Mackaness James H
CHIEF FINANCIAL OFFICER |
Sell | 25,799 @ $69.07 | $1.78 M | 149,377 | 03/27/2025 | 03/31/2025 | |
|
Yen Kristen
SEE REMARKS |
Sell | 5,239 @ $67.70 | $354,684 | 73,116 | 03/27/2025 | 03/31/2025 | |
|
Mackaness James H
CHIEF FINANCIAL OFFICER |
Sell | 563 @ $71.74 | $40,391 | 105,262 | 03/27/2025 | 03/31/2025 | |
|
Manning Meredith
Chief Commercial Officer |
Sell | 37,000 @ $67.04 | $2.48 M | 45,351 | 03/27/2025 | 03/31/2025 | |
|
Mackaness James H
CHIEF FINANCIAL OFFICER |
Sell | 1,669 @ $65.97 | $110,102 | 124,129 | 03/27/2025 | 03/31/2025 | |
|
Yen Kristen
SEE REMARKS |
Sell | 23,475 @ $66.95 | $1.57 M | 28,143 | 03/27/2025 | 03/31/2025 | |
|
Huang Michael F.
Sr. VP of Clinical Development |
Sell | 1,444 @ $68.79 | $99,330 | 37,883 | 03/27/2025 | 03/31/2025 | |
|
Mackaness James H
CHIEF FINANCIAL OFFICER |
Sell | 4,940 @ $67.70 | $334,441 | 116,472 | 03/27/2025 | 03/31/2025 | |
|
Manning Meredith
Chief Commercial Officer |
Sell | 155 @ $70.73 | $10,964 | 45,610 | 03/27/2025 | 03/31/2025 | |
|
Huang Michael F.
Sr. VP of Clinical Development |
Sell | 125 @ $71.74 | $8,968 | 36,836 | 03/27/2025 | 03/31/2025 | |
|
Huang Michael F.
Sr. VP of Clinical Development |
Sell | 86 @ $70.73 | $6,083 | 36,961 | 03/27/2025 | 03/31/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Soleno Therapeutics, Inc. FAQ's
The list of insiders at Soleno Therapeutics, Inc. includes Vivo Opportunity, LLC, Anish Bhatnagar, Hirano Patricia C, Mackaness James H, Yen Kristen, Huang Michael F., Manning Meredith, Pauls Matthew.
Insiders have sold a total of 4.77 M Soleno Therapeutics, Inc. shares in the last 12 months for a total of 279.14 M sold.
The following insiders have sold Soleno Therapeutics, Inc. shares in the last 12 months: Vivo Opportunity, LLC ($209.51 M), Anish Bhatnagar ($36.52 M), Hirano Patricia C ($12.10 M), Mackaness James H ($8.68 M), Yen Kristen ($7.85 M), Huang Michael F. ($1.01 M), Manning Meredith ($3.04 M), Pauls Matthew ($424,797),